The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Engelman, J. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2664 · Cited by 2,445
Hanna, N., Shepherd, F. A., Fossella, F. V., Pereira, J. R., De Marinis, F., von Pawel, J., Gatzemeier, U., Tsao, T. C. Y., Pless, M., Muller, T., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.163 · Cited by 2,426
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
The emerging mechanisms of isoform-specific PI3K signalling
Vanhaesebroeck, B., Guillermet-Guibert, J., Graupera, M., & Bilanges, B. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2882 · Cited by 1,767
The TSC1–TSC2 complex: a molecular switchboard controlling cell growth
Huang, J., & Manning, B. D. (2008) · Biochemical Journal · doi:10.1042/bj20080281 · Cited by 1,237
Making new contacts: the mTOR network in metabolism and signalling crosstalk
Shimobayashi, M., & Hall, M. N. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3757 · Cited by 1,053
Structure of the FKBP12-Rapamycin Complex Interacting with Binding Domain of Human FRAP
Choi, J., Chen, J., Schreiber, S. L., & Clardy, J. (1996) · Science · doi:10.1126/science.273.5272.239 · Cited by 929
Hirai, H., Sootome, H., Nakatsuru, Y., Miyama, K., Taguchi, S., Tsujioka, K., Ueno, Y., Hatch, H., Majumder, P. K., Pan, B.-S., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1012 · Cited by 860
Chresta, C. M., Davies, B. R., Hickson, I., Harding, T., Cosulich, S., Critchlow, S. E., Vincent, J. P., Ellston, R., Jones, D., Sini, P., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1751 · Cited by 812
Development of PI3K inhibitors: lessons learned from early clinical trials
Rodon, J., Dienstmann, R., Serra, V., & Tabernero, J. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.10 · Cited by 766
Genome Sequencing Identifies a Basis for Everolimus Sensitivity
Iyer, G., Hanrahan, A. J., Milowsky, M. I., Al-Ahmadie, H., Scott, S. N., Janakiraman, M., Pirun, M., Sander, C., Socci, N. D., Ostrovnaya, I., et al. (2012) · Science · doi:10.1126/science.1226344 · Cited by 690
Bendell, J. C., Rodon, J., Burris, H. A., de Jonge, M., Verweij, J., Birle, D., Demanse, D., De Buck, S. S., Ru, Q. C., Peters, M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.1360 · Cited by 684
Yap, T. A., Yan, L., Patnaik, A., Fearen, I., Olmos, D., Papadopoulos, K., Baird, R. D., Delgado, L., Taylor, A., Lupinacci, L., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.5263 · Cited by 539
Beuvink, I., Boulay, A., Fumagalli, S., Zilbermann, F., Ruetz, S., O’Reilly, T., Natt, F., Hall, J., Lane, H. A., & Thomas, G. (2005) · Cell · doi:10.1016/j.cell.2004.12.040 · Cited by 486
mTOR and cancer: many loops in one pathway
Efeyan, A., & Sabatini, D. M. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.10.007 · Cited by 430
Rekhtman, N., Paik, P. K., Arcila, M. E., Tafe, L. J., Oxnard, G. R., Moreira, A. L., Travis, W. D., Zakowski, M. F., Kris, M. G., & Ladanyi, M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2109 · Cited by 364
Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition
Faber, A. C., Li, D., Song, Y., Liang, M.-C., Yeap, B. Y., Bronson, R. T., Lifshits, E., Chen, Z., Maira, S.-M., García-Echeverría, C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905056106 · Cited by 319
Ihle, N. T., Williams, R., Chow, S., Chew, W., Berggren, M. I., Paine-Murrieta, G., Minion, D. J., Halter, R. J., Wipf, P., Abraham, R., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.763.3.7 · Cited by 313
Ihle, N. T., Lemos, R., Wipf, P., Yacoub, A., Mitchell, C., Siwak, D., Mills, G. B., Dent, P., Kirkpatrick, D. L., & Powis, G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-07-6656 · Cited by 274
Liu, N., Rowley, B. R., Bull, C. O., Schneider, C., Haegebarth, A., Schatz, C. A., Fracasso, P. R., Wilkie, D. P., Hentemann, M., Wilhelm, S. M., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0993-t · Cited by 258
Characterization of Torin2, an ATP-Competitive Inhibitor of mTOR, ATM, and ATR
Liu, Q., Xu, C., Kirubakaran, S., Zhang, X., Hur, W., Liu, Y., Kwiatkowski, N. P., Wang, J., Westover, K. D., Gao, P., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-1702 · Cited by 212
The Phosphatase PHLPP Controls the Cellular Levels of Protein Kinase C
Gao, T., Brognard, J., & Newton, A. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707319200 · Cited by 206
Chaft, J. E., Arcila, M. E., Paik, P. K., Lau, C., Riely, G. J., Pietanza, M. C., Zakowski, M. F., Rusch, V., Sima, C. S., Ladanyi, M., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0692 · Cited by 202
Jin, G., Kim, M. J., Jeon, H.-S., Choi, J. E., Kim, D. S., Lee, E. B., Cha, S. I., Yoon, G. S., Kim, C. H., Jung, T. H., et al. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2009.11.012 · Cited by 185
Spoerke, J. M., O'Brien, C., Huw, L., Koeppen, H., Fridlyand, J., Brachmann, R. K., Haverty, P. M., Pandita, A., Mohan, S., Sampath, D., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2347 · Cited by 182
Hong, D. S., Bowles, D. W., Falchook, G. S., Messersmith, W. A., George, G. C., O'Bryant, C. L., Vo, A. C. H., Klucher, K., Herbst, R. S., Eckhardt, S. G., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0714 · Cited by 169
Wang, L., Hu, H., Pan, Y., Wang, R., Li, Y., Shen, L., Yu, Y., Li, H., Cai, D., Sun, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088291 · Cited by 164
Soria, J.-C., Shepherd, F. A., Douillard, J.-Y., Wolf, J., Giaccone, G., Crino, L., Cappuzzo, F., Sharma, S., Gross, S. H., Dimitrijevic, S., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp060 · Cited by 163
Fu, L., Kim, Y.-A., Wang, X., Wu, X., Yue, P., Lonial, S., Khuri, F. R., & Sun, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2190 · Cited by 162
Ihle, N. T., Paine-Murrieta, G. D., Berggren, M. I., Baker, A. F., Tate, W. R., Wipf, P., Abraham, R. T., Kirkpatrick, D. L., & Powis, G. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0149 · Cited by 154
Shapiro, G. I., Rodon, J., Bedell, C., Kwak, E. L., Baselga, J., Braña, I., Pandya, S. S., Scheffold, C., Laird, A. D., Nguyen, L. T., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1777 · Cited by 152
Meng, J., Dai, B., Fang, B., Bekele, B. N., Bornmann, W. G., Sun, D., Peng, Z., Herbst, R. S., Papadimitrakopoulou, V. A., Minna, J. D., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014124 · Cited by 150
D-21266, a New Heterocyclic Alkylphospholipid with Antitumour Activity
Hilgard, P., Klenner, T., Stekar, J., Nössner, G., Kutscher, B., & Engel, J. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00466-2 · Cited by 144
Konstantinidou, G., Bey, E. A., Rabellino, A., Schuster, K., Maira, M. S., Gazdar, A. F., Amici, A., Boothman, D. A., & Scaglioni, P. P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0823 · Cited by 142
Scrima, M., Marco, C. D., Fabiani, F., Franco, R., Pirozzi, G., Rocco, G., Ravo, M., Weisz, A., Zoppoli, P., Ceccarelli, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030427 · Cited by 141
Kim, K. W., Moretti, L., Mitchell, L., Jung, D. K., & Lu, J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0589 · Cited by 121
Brachmann, S. M., Kleylein-Sohn, J., Gaulis, S., Kauffmann, A., Blommers, M. J. J., Kazic-Legueux, M., Laborde, L., Hattenberger, M., Stauffer, F., Vaxelaire, J., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-1021 · Cited by 121
Rivera, V. M., Squillace, R. M., Miller, D., Berk, L., Wardwell, S., Ning, Y., Pollock, R. M., Narasimhan, N. I., Iuliucci, J. D., Wang, F., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0792 · Cited by 114
Rapamycin Inhibits the Growth and Metastatic Progression of Non-Small Cell Lung Cancer
Boffa, D. J., Luan, F., Thomas, D. A., Yang, H., Sharma, V. K., Lagman, M., & Suthanthiran, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0629-3 · Cited by 105
Targeting KRAS-Mutant Non–Small Cell Lung Cancer with the Hsp90 Inhibitor Ganetespib
Acquaviva, J., Smith, D. L., Sang, J., Friedland, J. C., He, S., Sequeira, M., Zhang, C., Wada, Y., & Proia, D. A. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0615 · Cited by 101
Phase II Trial of Gefitinib and Everolimus in Advanced Non-small Cell Lung Cancer
Price, K. A. R., Azzoli, C. G., Krug, L. M., Pietanza, M. C., Rizvi, N. A., Pao, W. J., Kris, M. G., Riely, G. J., Heelan, R. T., Arcila, M. E., et al. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181ec1531 · Cited by 97
Holt, S. V., Logié, A., Davies, B. R., Alférez, D., Runswick, S. K., Fenton, S. E., Chresta, C. M., Gu, Y., Zhang, J., Wu, Y.-L. L. C., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1780 · Cited by 91
Highly frequent promoter methylation and PIK3CA amplification in non-small cell lung cancer (NSCLC)
Ji, M., Guan, H., Gao, C., Shi, B., & Hou, P. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-147 · Cited by 91
Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines
Monica, S. L., Galetti, M., Alfieri, R. R., Cavazzoni, A., Ardizzoni, A., Tiseo, M., Capelletti, M., Goldoni, M., Tagliaferri, S., Mutti, A., et al. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.033 · Cited by 88
Self-citationTOR kinase complexes and cell migration
Liu, L., & Parent, C. A. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201102090 · Cited by 87
Gorzalczany, Y., Gilad, Y., Amihai, D., Hammel, I., Sagi‐Eisenberg, R., & Merimsky, O. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.07.002 · Cited by 80
Xu, C., Li, Y., Yue, P., Owonikoko, T. K., Ramalingam, S. S., Khuri, F. R., & Sun, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020899 · Cited by 76
Xu, C., Zhao, L., Yue, P., Fang, G., Tao, H., Owonikoko, T. K., Ramalingam, S. S., Khuri, F. R., & Sun, S. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.6.16397 · Cited by 68
Besse, B., Leighl, N. B., Bennouna, J., Papadimitrakopoulou, V. A., Blais, N., Traynor, A. M., Soria, J., Gogov, S., Miller, N., Jehl, V., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt536 · Cited by 65
Zito, C. R., Jilaveanu, L. B., Anagnostou, V., Rimm, D. L., Bepler, G., Maira, S.-M., Hackl, W., Camp, R. L., Kluger, H. M., & Chao, H. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031331 · Cited by 61
Ren, H. J., Chen, M., Yue, P., Tao, H., Owonikoko, T. K., Ramalingam, S. S., Khuri, F. R., & Sun, S. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.06.018 · Cited by 58
Yanagawa, N., Leduc, C., Kohler, D. M., Saieg, M. A., John, T., Sykes, J. R., Yoshimoto, M., Pintilie, M., Squire, J. A., Shepherd, F. A., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182641d4f · Cited by 55
Zhang, X. (2011) · Molecular Medicine Reports · doi:10.3892/mmr.2011.682 · Cited by 52
Gonzalez-Angulo, A. M., Juric, D., Argilés, G., Schellens, J. H. M., Burris, H. A., Berlin, J. D., Middleton, M. R., Schüler, M., van Geel, R. M. J. M., Helgason, T., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.2531 · Cited by 52
Janne, P. A., Cohen, R. B., Laird, A., Macé, S., Engelman, J. A., Ruiz-Soto, R., Rockich, K. T., Xu, J., Shapiro, G. I., Martínez, P., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000088 · Cited by 50
Kim, E. J., Jeong, J., Bae, S., Kang, S., Kim, C. H., & Lim, Y. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24465 · Cited by 50
Reungwetwattana, T., Molina, J. R., Mandrekar, S. J., Allen-Ziegler, K., Rowland, K. M., Reuter, N. F., Luyun, R. F., Dy, G. K., Marks, R. S., Schild, S. E., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31824de0d6 · Cited by 48
Miyake, N., Chikumi, H., Takata, M., Nakamoto, M., Igishi, T., & Shimizu, E. (2012) · Oncology Reports · doi:10.3892/or.2012.1855 · Cited by 47
Stjernström, A., Karlsson, C., Fernandez, O. J., Söderkvist, P., Karlsson, M. G., & Thunell, L. K. (2014) · Cancer Medicine · doi:10.1002/cam4.191 · Cited by 47
Fei, S.-J., Zhang, X., Dong, S., Cheng, H., Yi-fang, Z., Huang, L., Zhou, H., Xie, Z., Chen, Z., & Wu, Y.-L. L. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069104 · Cited by 45
Juric, D., Krop, I. E., Ramanathan, R. K., Xiao, J. J., Sanabria, S., Wilson, T. R., Choi, Y., Parmar, H. R., Hsu, J. Y., Baselga, J. M., et al. (2013) · Cancer Research · doi:10.1158/1538-7445.am2013-lb-64 · Cited by 43
Li, X., Tong, L., Ding, J., & Meng, L. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.046 · Cited by 40
Ramalingam, S. S., Owonikoko, T. K., Behera, M., Subramanian, J., Saba, N. F., Kono, S. A., Gal, A. A., Sica, G., Harvey, R. D., Chen, Z., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318282709c · Cited by 40
Dong, S., Zhang, X., Cheng, H., Zhu, J., Chen, Z., Yi-fang, Z., Xie, Z., & Wu, Y.-L. L. C. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-1946-3 · Cited by 38
Vansteenkiste, J., Solomon, B., Boyer, M. J., Wolf, J., Miller, N., Scala, L. D., Pylvaenaeinen, I., Petrovic, K., Dimitrijević, S., Anrys, B., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182307ede · Cited by 33
Ohara, T., Takaoka, M., Toyooka, S., Tomono, Y., Nishikawa, T., Shirakawa, Y., Yamatsuji, T., Tanaka, N., Fujiwara, T., & Naomoto, Y. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01967.x · Cited by 32
Tan, D. S.-W., Lim, K. H., Tai, W. M. D., Ahmad, A., Pan, S., Ng, Q. S., Ang, M., Gogna, A., Ng, Y. L., Tan, B. S., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.8107 · Cited by 30
Ren, H. J., Zhao, L., Li, Y., Yue, P., Deng, X., Owonikoko, T. K., Chen, M., Khuri, F. R., & Sun, S. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.03.032 · Cited by 29
Cumberbatch, M., Tang, X., Beran, G. J., Eckersley, S., Wang, X., Ellston, R. P. A., Dearden, S. P., Cosulich, S. C., Smith, P. D., Behrens, C., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1638 · Cited by 27
Nakachi, I., Naoki, K., Soejima, K., Kawada, I., Watanabe, H., Yasuda, H., Nakayama, S., Yoda, S., Satomi, R., Ikemura, S., et al. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0388 · Cited by 26
A Phase I Trial of Sunitinib and Rapamycin in Patients with Advanced Non-Small Cell Lung Cancer
Waqar, S. N., Gopalan, P. K., Williams, K., Devarakonda, S. H. K., & Govindan, R. (2013) · Chemotherapy · doi:10.1159/000348584 · Cited by 24
Blockage of Stat3 enhances the sensitivity of NSCLC cells to PI3K/mTOR inhibition
Jin, H., Lee, Y.-H., Park, J.-A., Kim, J. H., Hong, S.-E., Kim, H., Kim, E., Noh, W. C., Kim, B., Ye, S., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.086 · Cited by 24
A Phase I Study of Temsirolimus and Thoracic Radiation in Non–Small-Cell Lung Cancer
Waqar, S. N., Robinson, C. G., Bradley, J. D., Goodgame, B. W., Rooney, M., Williams, K., Gao, F., & Govindan, R. (2013) · Clinical Lung Cancer · doi:10.1016/j.cllc.2013.11.007 · Cited by 23
Chen, B., Sun, Y., & Ni, J. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-0724-3 · Cited by 19
Huang, Y., Chen, Y., MEI, Q., Chen, Y., Yu, S., & Xia, S. (2013) · Oncology Reports · doi:10.3892/or.2013.2357 · Cited by 17
Tuberous-sclerosis complex-related cell signaling in the pathogenesis of lung cancer
Fuchs, A., König, K., Heukamp, L. C., Fassunke, J., Kirfel, J., Huss, S., Becker, A. J., Büttner, R., & Majores, M. (2014) · Diagnostic Pathology · doi:10.1186/1746-1596-9-48 · Cited by 9
Cited by
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer
Yu, L., Wei, J., & Liu, P. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.06.019 · Cited by 763
The emerging treatment landscape of targeted therapy in non-small-cell lung cancer
Yuan, M., Huang, L.-L., Chen, J.-H., Wu, J., & Xu, Q. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0099-9 · Cited by 679
Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer
Liu, G., Pei, F., Yang, F., Li, L., Amin, A., Liu, S., Buchan, J., & Cho, W. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020367 · Cited by 425
Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets
Ballester, B., Milara, J., & Cortijo, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030593 · Cited by 308
Metadata
- Authors
- Fumarola, C., Bonelli, M. A., Petronini, P. G., & Alfieri, R. R.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 90
- Issue
- 3
- Pages
- 197-207
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2005403381
- Cited by
- 463
- References
- 76
- FWCI
- 12.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.